Key roles of the OPG-RANK-RANKL system in bone oncology

Baud'huin, M., Duplomb, L., Velasco, C.R. et al. (3 more authors) (2007) Key roles of the OPG-RANK-RANKL system in bone oncology. Expert Review of Anticancer Therapy, 7 (2). pp. 221-232. ISSN 1473-7140

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2007 Taylor & Francis.
Keywords: bone; metastases; OPG; osteoblast; osteoclast; osteolysis; primary tumor; RANKL; secondary tumor; FACTOR-KAPPA-B; MEDIATES OSTEOCLAST DIFFERENTIATION; TRAIL-INDUCED APOPTOSIS; PROSTATE-CANCER CELLS; FORMATION IN-VITRO; RECEPTOR ACTIVATOR; MULTIPLE-MYELOMA; OSTEOPROTEGERIN OPG; BREAST-CANCER; POSTMENOPAUSAL WOMEN
Dates:
  • Published: February 2007
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 25 Apr 2016 13:52
Last Modified: 15 Nov 2016 19:28
Published Version: http://dx.doi.org/10.1586/14737140.7.2.221
Status: Published
Publisher: Taylor & Francis
Refereed: Yes
Identification Number: https://doi.org/10.1586/14737140.7.2.221

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics